摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Ethyl-but-1-yl-carbamat | 24847-58-3

中文名称
——
中文别名
——
英文名称
2-Ethyl-but-1-yl-carbamat
英文别名
2-ethylbutyl carbamate;carbamic acid-(2-ethyl-butyl ester);3-Carbamoyloxymethyl-pentan;Carbamidsaeure-(2-aethyl-butylester);2-Aethyl-1-carbamoyloxy-butan;2-Ethyl-Butyl Carbamate
2-Ethyl-but-1-yl-carbamat化学式
CAS
24847-58-3
化学式
C7H15NO2
mdl
MFCD19204205
分子量
145.202
InChiKey
IACWDLHSJCOUGC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    237.3±8.0 °C(Predicted)
  • 密度:
    0.957±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    10
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.857
  • 拓扑面积:
    52.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    2-Ethyl-but-1-yl-carbamat乙醛盐酸乙醚 作用下, 生成 N,N'-ethylidene-bis-carbamic acid bis-(2-ethyl-butyl ester)
    参考文献:
    名称:
    Kraft; Herbst, Journal of Organic Chemistry, 1945, vol. 10, p. 492
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    Taillandier; Benoit Guyod; Boucherle, European Journal of Medicinal Chemistry, 1975, vol. 10, # 5, p. 453 - 462
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR ANEMIA COMPRISING TETRAHYDROQUINOLINE COMPOUND AS ACTIVE INGREDIENT
    申请人:Ashikawa Masanori
    公开号:US20120004197A1
    公开(公告)日:2012-01-05
    Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin. Specifically disclosed is and EPO production enhancer and/or a hemoglobin production enhancer comprising a 1-acyl-4-(substituted oxy, substituted amino, or substituted thio)-1,2,3,4-tetrahydroquinoline derivative, more specifically a tetrahydroquinoline compound represented by general formula (1) [wherein R 1 , R 2 , R 2′ , R 3 and R 3′ independently represent a hydrogen atom, a C 1-6 alkyl group, or the like; R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 independently represent a hydrogen atom, a halogen atom, a C 1-6 alkyl group, or the like; A represents N—R 11 , a sulfur atom, or an oxygen atom; R 11 represents a hydrogen atom, a C 1-6 alkyl group, or the like; B represents a C 6-14 aryl group, or a 5- to 10-membered heterocyclic group; and n represents an integer of 0 or 1], a salt of the tetrahydroquinoline compound, or a solvate of the tetrahydroquinoline compound or the salt.
    揭示了一种具有低分子量的化合物,具有增强EPO产生和/或增强血红蛋白产生活性的化合物。具体揭示了一种EPO产生增强剂和/或血红蛋白产生增强剂,包括1-酰基-4-(取代氧基、取代氨基或取代硫基)-1,2,3,4-四氢喹啉衍生物,更具体地说是由通式(1)表示的四氢喹啉化合物【其中R1、R2、R2'、R3和R3'独立地表示氢原子、C1-6烷基或类似物;R4、R5、R6、R7、R8、R9和R10独立地表示氢原子、卤素原子、C1-6烷基或类似物;A表示N—R11、硫原子或氧原子;R11表示氢原子、C1-6烷基或类似物;B表示C6-14芳基或5-至10-成员杂环基;n表示0或1的整数】,四氢喹啉化合物的盐,或四氢喹啉化合物或其盐的溶剂化合物。
  • Syntheses and Evaluation of Anticonvulsant Activity of Novel Branched Alkyl Carbamates
    作者:Naama Hen、Meir Bialer、Boris Yagen
    DOI:10.1021/jm201751x
    日期:2012.3.22
    2-ethyl-3-methyl-butyl-carbamate (34) and 2-ethyl-3-methyl-pentyl-carbamate (38) also exhibited potent activity in the pilocarpine-SE model 30 min postseizure onset. Extending the aliphatic side chains of homologous carbamates from 7 to 8 (34 to 35) and from 8 to 9 carbons in the homologues 38 and 43 decreased the activity in the pilocarpine-SE model from ED50 = 81 mg/kg (34) to 94 mg/kg (35) and from 96 mg/kg (38)
    合成了一类新型的19种氨基甲酸酯,并在大鼠最大电击(MES)和皮下甲硝唑(scMet)癫痫发作测试和毛果芸香碱引起的癫痫持续状态(SE)模型中比较了它们的抗惊厥活性。尽管所述烷基氨基甲酸酯紧密的结构特征,仅化合物34,38,和40都处于活动状态的MES试验。癫痫发作后30分钟,类似物2-乙基-3-甲基-丁基-氨基甲酸酯(34)和2-乙基-3-甲基-戊基-氨基甲酸酯(38)也表现出有效的活性。将同源氨基甲酸酯的脂族侧链从7延伸到8(34到35)和同源物38和43中的8至9个碳降低了毛果芸豆SE模型中的活性,从ED 50 = 81 mg / kg(34)降至94 mg / kg(35)和96 mg / kg(38)。分别达到114 mg / kg(43)。最有效的氨基甲酸酯,苯基-乙基-氨基甲酸酯(47)(MES ED 50 = 16 mg / kg)在其结构中包含一个芳香族部分。化合物34,
  • PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR ANEMIA, COMPRISING TETRAHYDROQUINOLINE COMPOUND AS ACTIVE INGREDIENT
    申请人:Kowa Company, Ltd.
    公开号:EP2199283A1
    公开(公告)日:2010-06-23
    Disclosed is a low-molecular-weight compound having an EPO production-promoting activity and/or a hemoglobin expression-enhancing activity. Specifically disclosed is an EPO production promoter and/or a hemoglobin expression enhancer comprising a 1-acyl-4-(phenoxy, benzyloxy or phenylamino)-1,2,3,4-tetrahydroquinoline derivative, more specifically a tetrahydroquinoline compound represented by the general formula (1); [wherein R1, R2, R2', R3 and R3' independently represent a hydrogen atom, a C1-6 alkyl group, or the like; R4, R5, R6, R7, R8, R9 and R10 independently represent a hydrogen atom, a halogen atom, a C1-6 alkyl group, or the like; A represents N-R11 or an oxygen atom; R11 represents a hydrogen atom, a C1-6 alkyl group, or the like; and n represents an integer of 0 or 1], a salt of the tetrahydroquinoline compound, or a solvate of the tetrahydroquinoline compound or the salt.
    本文披露了一种具有促进EPO产生活性和/或增强血红蛋白表达活性的低分子化合物。具体披露了一种EPO产生促进剂和/或血红蛋白表达增强剂,包括1-酰基-4-(苯氧基、苄氧基或苯基氨基)-1,2,3,4-四氢喹啉衍生物,更具体地说是由通式(1)表示的四氢喹啉化合物;[其中R1、R2、R2'、R3和R3'独立地表示氢原子、C1-6烷基或类似物;R4、R5、R6、R7、R8、R9和R10独立地表示氢原子、卤素原子、C1-6烷基或类似物;A表示N-R11或氧原子;R11表示氢原子、C1-6烷基或类似物;n表示0或1的整数],四氢喹啉化合物的盐,或四氢喹啉化合物或其盐的溶剂结晶体。
  • Quantitative structure-activity relationships of anticonvulsant aralkyl and alkyl carbamates.
    作者:MITSUYO TANAKA、KAZUYOSHI HORISAKA、CHISAKO YAMAGAMI、NARAO TAKAO、TOSHIO FUJITA
    DOI:10.1248/cpb.33.2403
    日期:——
    A series of aralkyl and alkyl carbamates of the type R1OCONR2R3 (R1=alkyl or aralkyl, R2, R3=H, Me, Et) were prepared and tested for anticonvulsant activity in mice by means of the maximal electroshock seizure test. The ED50 values were analyzed in terms of hydrophobic (log P), electronic (σ1) and other parameters by regression analysis. The results are essentially the same as those for previously studied m-and p-substituted benzyl N, N-dimethylcarbamates (X-C6H4-CH2OCONMe2). The activity depended parabolically on log P with an optimum log P of 1.7, and was negatively correlated with σ1. It was also found that the potency is reduced when R1 is an alkyl group or includes a hydrogen-bonding group. Structural requirements for the optimal potency and the aromatic ring contribution to the activity are discussed.
    一系列类型为 R1OCONR2R3(R1=烷基或芳香烷基,R2、R3=氢、甲基、乙基)的芳烷基和烷基氨基甲酸酯被合成并通过最大电击惊厥测试在小鼠中测试其抗惊厥活性。ED50 值通过回归分析在疏水性 (log P)、电子性 (σ1) 和其他参数的基础上进行了分析。结果与之前研究的 m-和 p-取代苯基 N,N-二甲基氨基甲酸酯 (X-C6H4-CH2OCONMe2) 的结果基本相同。活性与 log P 呈抛物线关系,最佳 log P 为 1.7,并与 σ1 负相关。还发现,当 R1 为烷基或包含氢键结合基时,活性降低。讨论了最佳活性的结构要求以及芳香环对活性的贡献。
  • 3-phenoxy-4-pyridazinol derivatives and herbicide composition containing the same
    申请人:Tsukamoto Yoshihisa
    公开号:US20050037925A1
    公开(公告)日:2005-02-17
    A compound represented by the formula: [wherein R 1 represents a hydrogen atom, a halogen, atom, alkyl group, etc., R 2 represents a hydrogen atom, a halogen atom, alkyl group, etc., R 3 , R 4 , R 5 , R 6 and R 7 each independently represent a hydrogen atom, a halogen atom, a substitutable alkyl group, a substitutable alkenyl group, alkynyl group, a substituteable cycloalkyl group, etc., or R 3 , R 4 , R 5 , R 6 and R 7 may form a ring which may be substituted, which is formed by the adjacent two of them with carbon atoms to which the respective substituents are bonded, m and n each independently represent 0 or 1.] a salt thereof, an ester derivative thereof and an agricultural chemical containing the same as an effective ingredient, and a herbicidal composition containing the compound and a second herbicidally active compound as effective ingredients.
    一种化合物由以下式子表示:[其中R1代表氢原子,卤素原子,烷基团等,R2代表氢原子,卤素原子,烷基团等,R3,R4,R5,R6和R7各自独立地代表氢原子,卤素原子,可替换的烷基团,可替换的烯基团,炔基团,可替换的环烷基团等,或R3,R4,R5,R6和R7可以形成一个环,该环可以被取代,该环由相邻的两个碳原子形成,这些碳原子与相应的取代基团相连,m和n各自独立地代表0或1。]其盐,酯衍生物及含有该化合物为有效成分的农药,以及含有该化合物和第二种草甘膦活性化合物为有效成分的除草剂组合物。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物